Re: Comparison of immediate vs. deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial

被引：1
|
作者：
Minervini, Andrea [1 ]
Mari, Andrea [1 ]
Di Maida, Fabrizio [1 ]
Campi, Riccardo [1 ]
Carini, Marco [1 ]
Lapini, Alberto [1 ]
机构：
[1] Univ Florence, Careggi Hosp, Unit Oncol Minimally Invas Urol & Androl, Dept Urol, Florence, Italy
来源：
TRANSLATIONAL CANCER RESEARCH | 2019年 / 8卷
关键词：
INTERFERON-ALPHA; MONOTHERAPY; CANCER;
D O I：
10.21037/tcr.2019.03.08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S208 / S210
页数：3
相关论文
共 50 条
  • [31] Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Heng, Daniel Y. C.
    Wells, J. Connor
    Rini, Brian I.
    Beuselinck, Benoit
    Lee, Jae-Lyun
    Knox, Jennifer J.
    Bjarnason, Georg A.
    Pal, Sumanta Kumar
    Kollmannsberger, Christian K.
    Yuasa, Takeshi
    Srinivas, Sandy
    Donskov, Frede
    Bamias, Aristotelis
    Wood, Lori A.
    Ernst, D. Scott
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Rha, Sun Young
    Kim, Jenny J.
    Choueiri, Toni K.
    EUROPEAN UROLOGY, 2014, 66 (04) : 704 - 710
  • [32] CARMENA: Cytoreductive nephrectomy followed by sunitinib versus sunitinib alone in metastatic renal cell carcinoma-Results of a phase III noninferiority trial.
    Mejean, Arnaud
    Escudier, Bernard
    Thezenas, Simon
    Beauval, Jean-Baptiste
    Geoffroy, Lionnel
    Bensalah, Karim
    Thiery-Vuillemin, Antoine
    Cormier, Luc
    Lang, Herve
    Guy, Laurent
    Gravis, Gwenaelle
    Rolland, Frederic
    Linassier, Claude
    Timsit, Marc Olivier
    Albiges, Laurence
    Beisland, Christian
    Aitchison, Michael
    Colas, Sandra
    Lebret, Thierry
    Ravaud, Alain
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18)
  • [33] PROGRESSION-FREE AND OVERALL SURVIVAL OF PATIENTS TREATED WITH PRESURGICAL SUNITINIB PRIOR TO CYTOREDUCTIVE NEPHRECTOMY (CN) IN CLEAR CELL SYNCHRONOUS METASTATIC RENAL CELL CARCINOMA (MRCC)
    Bex, Axel
    Blank, Christian
    Chowdhury, Simon
    Nichol, David
    Peters, John
    Horenblas, Simon
    O'Brien, Tim
    Sarwar, Naveed
    Haanen, John
    Powles, Thomas
    JOURNAL OF UROLOGY, 2011, 185 (04): : E709 - E710
  • [34] SEQUENTIAL TARGET THERAPY FOR METASTATIC RENAL CELL CARCINOMA: COMPARISON OF SUNITINIB+SORAFENIB VS. SORAFENIB+SUNITINIB
    Antonelli, Alessandro
    Daja, Julian
    Ferrari, Vittorio
    Arrighi, Nicola
    Cunico, Sergio Cosciani
    Simeone, Claudio
    ANTICANCER RESEARCH, 2011, 31 (05) : 1922 - 1923
  • [35] Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib
    Iacovelli, Roberto
    Carteni, Giacomo
    Milella, Michele
    Berardi, Rossana
    Di Lorenzo, Giuseppe
    Verzoni, Elena
    Rizzo, Mimma
    Santoni, Matteo
    Procopio, Giuseppe
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (3-4): : E121 - E125
  • [36] Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Takemura, Kosuke
    Ernst, Matthew S.
    Navani, Vishal
    Wells, J. Connor
    Bakouny, Ziad
    Donskov, Frede
    Basappa, Naveen S.
    Wood, Lori A.
    Meza, Luis
    Pal, Sumanta K.
    Szabados, Bernadett
    Powles, Thomas
    Beuselinck, Benoit
    Mckay, Rana R.
    Lee, Jae-Lyun
    Ernst, D. Scott
    Kapoor, Anil
    Yuasa, Takeshi
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 501 - 508
  • [37] CLINICAL VARIABLES FOR PREDICTING METASTATIC RENAL CELL CARCINOMA PATIENTS WHO WILL NOT BENEFIT FROM CYTOREDUCTIVE NEPHRECTOMY
    Ohno, Yoshio
    Nakashima, Jun
    Ohori, Makoto
    Hashimoto, Takeshi
    Gondo, Tatsuo
    Okubo, Hideki
    Shimodaira, Kenji
    Tachibana, Masaaki
    JOURNAL OF UROLOGY, 2012, 187 (04): : E806 - E807
  • [38] Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma
    Bex, Axel
    Albiges, Laurence
    Ljungberg, Borje
    Bensalah, Karim
    Dabestani, Saeed
    Giles, Rachel H.
    Hofmann, Fabian
    Hora, Milan
    Kuczyk, Markus A.
    Lam, Thomas B.
    Marconi, Lorenzo
    Merseburger, Axel S.
    Fernandez-Pello, Sergio
    Tahbaz, Rana
    Abu-Ghanem, Yasmin
    Staehler, Michael
    Volpe, Alessandro
    Powles, Thomas
    EUROPEAN UROLOGY, 2018, 74 (06) : 805 - 809
  • [39] Re: Clinical Outcomes for Patients with Metastatic Renal Cell Carcinoma Treated with Alternative Sunitinib Schedules
    Zigeuner, Richard
    EUROPEAN UROLOGY, 2014, 66 (04) : 785 - 785
  • [40] Impact of Prior Cytoreductive Nephrectomy on Efficacy in Patients with Synchronous Metastatic Renal Cell Carcinoma Treated with Avelumab plus Axitinib or Sunitinib: Post Hoc Analysis from the JAVELIN Renal 101 Phase 3 Trial
    Grimm, Marc-Oliver
    Oya, Mototsugu
    Choueiri, Toni K.
    Motzer, Robert J.
    Schmidinger, Manuela
    Quinn, David I.
    Gravis-Mescam, Gwenaelle
    Verzoni, Elena
    Van den Eertwegh, Alfonsus J. M.
    di Pietro, Alessandra
    Mariani, Mariangela
    Wang, Jing
    Thomaidou, Despina
    Albiges, Laurence
    EUROPEAN UROLOGY, 2024, 85 (01) : 8 - 12
12345